Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About AVG Technologies NV (AVG)

Page 1 of 2

Is it smart to be bullish on AVG Technologies NV (NYSE:AVG)?

At the moment, there are tons of indicators market participants can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite fund managers can outperform the broader indices by a very impressive margin (see just how much).

Just as crucial, optimistic insider trading sentiment is another way to look at the investments you’re interested in. As the old adage goes: there are plenty of motivations for a bullish insider to sell shares of his or her company, but just one, very clear reason why they would buy. Several academic studies have demonstrated the impressive potential of this tactic if investors know what to do (learn more here).

Keeping this in mind, it’s important to examine the latest info about AVG Technologies NV (NYSE:AVG).

How are hedge funds trading AVG Technologies NV (NYSE:AVG)?

In preparation for the third quarter, a total of 14 of the hedge funds we track were long in this stock, a change of -7% from the first quarter. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were upping their stakes significantly.

AVG Technologies NV (NYSE:AVG)According to our 13F database, Ahmet Okumus’s Okumus Fund Management had the largest position in AVG Technologies NV (NYSE:AVG), worth close to $106.2 million, accounting for 60.6% of its total 13F portfolio. Sitting at the No. 2 spot is Renaissance Technologies, managed by Jim Simons, which held a $6.5 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Remaining hedgies that are bullish include John Thaler’s JAT Capital Management, Robert B. Gillam’s McKinley Capital Management and John Overdeck and David Siegel’s Two Sigma Advisors.

Because AVG Technologies NV (NYSE:AVG) has experienced a fall in interest from the smart money’s best and brightest, it’s safe to say that there exists a select few hedgies who were dropping their entire stakes heading into Q2. It’s worth mentioning that Brett Hendrickson’s Nokomis Capital sold off the largest stake of the 450+ funds we track, valued at an estimated $8.7 million in stock, and John A. Levin of Levin Capital Strategies was right behind this move, as the fund cut about $0.7 million worth. These moves are intriguing to say the least, as total hedge fund interest was cut by 1 funds heading into Q2.

How have insiders been trading AVG Technologies NV (NYSE:AVG)?

Insider buying made by high-level executives is best served when the company in focus has seen transactions within the past half-year. Over the last half-year time period, AVG Technologies NV (NYSE:AVG) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to AVG Technologies NV (NYSE:AVG). These stocks are FleetMatics Group PLC (NYSE:FLTX), Lifelock Inc (NYSE:LOCK), BroadSoft Inc (NASDAQ:BSFT), PROS Holdings, Inc. (NYSE:PRO), and Demandware Inc (NYSE:DWRE). This group of stocks are the members of the application software industry and their market caps are similar to AVG’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!